Profiles

Kevin Outterson, JD, LLM

(617) 358-2047

mko@bu.edu

Talbot

Biography

Research interests in pharmaceutical innovation, including the law & economics of antimicrobial resistance.

Professor of Law and N. Neal Pike Scholar, Health and Disability Law - Boston University School of Law
Executive Director of CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) - Boston University School of Law

Published on 1/29/2026
Goh M, Outterson K, Kesselheim AS. Priority without progress: the FDA's neglected tropical disease voucher program after 18 years. Health Aff Sch. 2026 Feb; 4(2):qxag024. PMID: 41710508.
Read At: PubMed

Published on 12/2/2025
Poirier MJ, Singh J, Weldon I, Chandler CI, Corno D, Valtere L, Batista PHD, Carelli D, Boily-Larouche G, Lewycka S, Emdin F, Liddell K, Minssen T, Natali I, Nayiga S, Okeke IN, Olamijuwon E, Outterson K, Piper J, Strong K, Thakur JS, Thavorn K, Van Der Heijden M, Viens AM, Wiktorowicz M, Hoffman SJ. Social science contributions to the global action plan on antimicrobial resistance. Bull World Health Organ. 2026 Jan 01; 104(1):53-55. PMID: 41409099.
Read At: PubMed

Published on 9/30/2025
Goh M, Viens AM, Abdool Karim S, Kesselheim AS, Outterson K. Whose burden, whose benefit? Revisiting ethical trade-offs in the WHO guidelines on scaling up mass azithromycin administration. PLoS Med. 2025 Sep; 22(9):e1004736. PMID: 41026666.
Read At: PubMed

Published on 9/8/2025
Goh M, McEnany M, Freeman R, Newton M, Kesselheim AS, Outterson K. Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27. EClinicalMedicine. 2025 Oct; 88:103485. PMID: 40989242.
Read At: PubMed

Published on 8/28/2025
Weldon I, Liddell K, Outterson K. Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental Governance. Milbank Q. 2025 Dec; 103(4):1003-1046. PMID: 40876865.
Read At: PubMed

Published on 7/2/2025
Goh M, Outterson K, Kesselheim AS. Examining Pricing and Availability for Neglected Tropical Disease Therapies in the United States. Open Forum Infect Dis. 2025 Jul; 12(7):ofaf391. PMID: 40689243.
Read At: PubMed

Published on 4/30/2025
Mossialos E, Outterson K, Davies S, Anderson M. The antimicrobial resistance cube: a framework for identifying policy gaps and driving action. Lancet. 2025 Apr 30. PMID: 40318688.
Read At: PubMed

Published on 3/24/2025
Robertson C, McCuskey E, Ahmed A, Lomax D, Zeiler K, McCarthy D, Stephens L, Ulrich M, Vernaglia L, Duryea DP, Huberfeld N, Outterson K. Celebrating 70 Years of Health Law at BU. Am J Law Med. 2024 Dec; 50(3-4):149-160. PMID: 40126117.
Read At: PubMed

Published on 11/29/2024
Chong CE, Pham TM, Carey ME, Wee BA, Taouk ML, Favieres JF, Moore CE, Dyson ZA, Lim C, Brown CL, Williamson D, Opatowski L, Outterson K, Mukiri KM, Sherry NL, Essack SY, Brisse S, Grad YH, Baker KS. Conference report of the 2024 Antimicrobial Resistance Meeting. NPJ Antimicrob Resist. 2024 Nov 29; 2(1):43. PMID: 39843763.
Read At: PubMed

Published on 11/28/2024
Goh M, Kesselheim AS, Outterson K. Azithromycin to Reduce Mortality. N Engl J Med. 2024 Nov 28; 391(21):2060. PMID: 39602642.
Read At: PubMed

View 92 more publications:View Full Profile at BUMC